The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Protein Therapeutics Market Research Report 2025
Synopsis
In the 1970s, recombinant DNA technology hardly opened a new era of pharmaceutical biotechnology. Therefore, the definition of protein therapeutics covers drugs that are structurally proteins or peptides, as well as drugs obtained through recombinant DNA technology.
The global Recombinant Protein Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Therapeutics.
Report Scope
The Recombinant Protein Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Protein Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Protein Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
Merck
Roche
Biogen
Bayer
J&J
Amgen
Sanofi
Ligand
Segment by Type
Recombinant Hormones
Interferons
Interleukins
Hematopoietic Growth Factors
Others
Segment by Application
Diabetes
Dwarfism
Heart Disease
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In the 1970s, recombinant DNA technology hardly opened a new era of pharmaceutical biotechnology. Therefore, the definition of protein therapeutics covers drugs that are structurally proteins or peptides, as well as drugs obtained through recombinant DNA technology.
The global Recombinant Protein Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Therapeutics.
Report Scope
The Recombinant Protein Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Protein Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Protein Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
Merck
Roche
Biogen
Bayer
J&J
Amgen
Sanofi
Ligand
Segment by Type
Recombinant Hormones
Interferons
Interleukins
Hematopoietic Growth Factors
Others
Segment by Application
Diabetes
Dwarfism
Heart Disease
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Recombinant Hormones
1.2.3 Interferons
1.2.4 Interleukins
1.2.5 Hematopoietic Growth Factors
1.2.6 Others
1.3 Market by Application
1.3.1 Global Recombinant Protein Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diabetes
1.3.3 Dwarfism
1.3.4 Heart Disease
1.3.5 Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Protein Therapeutics Market Perspective (2019-2030)
2.2 Recombinant Protein Therapeutics Growth Trends by Region
2.2.1 Global Recombinant Protein Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Recombinant Protein Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Recombinant Protein Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Recombinant Protein Therapeutics Market Dynamics
2.3.1 Recombinant Protein Therapeutics Industry Trends
2.3.2 Recombinant Protein Therapeutics Market Drivers
2.3.3 Recombinant Protein Therapeutics Market Challenges
2.3.4 Recombinant Protein Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Therapeutics Players by Revenue
3.1.1 Global Top Recombinant Protein Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Recombinant Protein Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Recombinant Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Protein Therapeutics Revenue
3.4 Global Recombinant Protein Therapeutics Market Concentration Ratio
3.4.1 Global Recombinant Protein Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Therapeutics Revenue in 2023
3.5 Recombinant Protein Therapeutics Key Players Head office and Area Served
3.6 Key Players Recombinant Protein Therapeutics Product Solution and Service
3.7 Date of Enter into Recombinant Protein Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Protein Therapeutics Breakdown Data by Type
4.1 Global Recombinant Protein Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Recombinant Protein Therapeutics Forecasted Market Size by Type (2025-2030)
5 Recombinant Protein Therapeutics Breakdown Data by Application
5.1 Global Recombinant Protein Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Recombinant Protein Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Recombinant Protein Therapeutics Market Size (2019-2030)
6.2 North America Recombinant Protein Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Recombinant Protein Therapeutics Market Size by Country (2019-2024)
6.4 North America Recombinant Protein Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Protein Therapeutics Market Size (2019-2030)
7.2 Europe Recombinant Protein Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Recombinant Protein Therapeutics Market Size by Country (2019-2024)
7.4 Europe Recombinant Protein Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Recombinant Protein Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Recombinant Protein Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Recombinant Protein Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Protein Therapeutics Market Size (2019-2030)
9.2 Latin America Recombinant Protein Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Recombinant Protein Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Recombinant Protein Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Recombinant Protein Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Recombinant Protein Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Recombinant Protein Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Recombinant Protein Therapeutics Introduction
11.1.4 Eli Lilly Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Recombinant Protein Therapeutics Introduction
11.2.4 Pfizer Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Recombinant Protein Therapeutics Introduction
11.3.4 Merck Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Recombinant Protein Therapeutics Introduction
11.4.4 Roche Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Biogen
11.5.1 Biogen Company Detail
11.5.2 Biogen Business Overview
11.5.3 Biogen Recombinant Protein Therapeutics Introduction
11.5.4 Biogen Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.5.5 Biogen Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Recombinant Protein Therapeutics Introduction
11.6.4 Bayer Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 J&J
11.7.1 J&J Company Detail
11.7.2 J&J Business Overview
11.7.3 J&J Recombinant Protein Therapeutics Introduction
11.7.4 J&J Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.7.5 J&J Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Recombinant Protein Therapeutics Introduction
11.8.4 Amgen Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.8.5 Amgen Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Recombinant Protein Therapeutics Introduction
11.9.4 Sanofi Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 Ligand
11.10.1 Ligand Company Detail
11.10.2 Ligand Business Overview
11.10.3 Ligand Recombinant Protein Therapeutics Introduction
11.10.4 Ligand Revenue in Recombinant Protein Therapeutics Business (2019-2024)
11.10.5 Ligand Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Recombinant Protein Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Recombinant Hormones
Table 3. Key Players of Interferons
Table 4. Key Players of Interleukins
Table 5. Key Players of Hematopoietic Growth Factors
Table 6. Key Players of Others
Table 7. Global Recombinant Protein Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Recombinant Protein Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Recombinant Protein Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Recombinant Protein Therapeutics Market Share by Region (2019-2024)
Table 11. Global Recombinant Protein Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Recombinant Protein Therapeutics Market Share by Region (2025-2030)
Table 13. Recombinant Protein Therapeutics Market Trends
Table 14. Recombinant Protein Therapeutics Market Drivers
Table 15. Recombinant Protein Therapeutics Market Challenges
Table 16. Recombinant Protein Therapeutics Market Restraints
Table 17. Global Recombinant Protein Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Recombinant Protein Therapeutics Market Share by Players (2019-2024)
Table 19. Global Top Recombinant Protein Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Therapeutics as of 2023)
Table 20. Ranking of Global Top Recombinant Protein Therapeutics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Recombinant Protein Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Recombinant Protein Therapeutics Product Solution and Service
Table 24. Date of Enter into Recombinant Protein Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Recombinant Protein Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Recombinant Protein Therapeutics Revenue Market Share by Type (2019-2024)
Table 28. Global Recombinant Protein Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Recombinant Protein Therapeutics Revenue Market Share by Type (2025-2030)
Table 30. Global Recombinant Protein Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Recombinant Protein Therapeutics Revenue Market Share by Application (2019-2024)
Table 32. Global Recombinant Protein Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Recombinant Protein Therapeutics Revenue Market Share by Application (2025-2030)
Table 34. North America Recombinant Protein Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Recombinant Protein Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Recombinant Protein Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Recombinant Protein Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Recombinant Protein Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Recombinant Protein Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Recombinant Protein Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Recombinant Protein Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Recombinant Protein Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Recombinant Protein Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Recombinant Protein Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Recombinant Protein Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Recombinant Protein Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Recombinant Protein Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Recombinant Protein Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Eli Lilly Company Detail
Table 50. Eli Lilly Business Overview
Table 51. Eli Lilly Recombinant Protein Therapeutics Product
Table 52. Eli Lilly Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 53. Eli Lilly Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Recombinant Protein Therapeutics Product
Table 57. Pfizer Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Merck Company Detail
Table 60. Merck Business Overview
Table 61. Merck Recombinant Protein Therapeutics Product
Table 62. Merck Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 63. Merck Recent Development
Table 64. Roche Company Detail
Table 65. Roche Business Overview
Table 66. Roche Recombinant Protein Therapeutics Product
Table 67. Roche Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Biogen Company Detail
Table 70. Biogen Business Overview
Table 71. Biogen Recombinant Protein Therapeutics Product
Table 72. Biogen Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Biogen Recent Development
Table 74. Bayer Company Detail
Table 75. Bayer Business Overview
Table 76. Bayer Recombinant Protein Therapeutics Product
Table 77. Bayer Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Bayer Recent Development
Table 79. J&J Company Detail
Table 80. J&J Business Overview
Table 81. J&J Recombinant Protein Therapeutics Product
Table 82. J&J Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 83. J&J Recent Development
Table 84. Amgen Company Detail
Table 85. Amgen Business Overview
Table 86. Amgen Recombinant Protein Therapeutics Product
Table 87. Amgen Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 88. Amgen Recent Development
Table 89. Sanofi Company Detail
Table 90. Sanofi Business Overview
Table 91. Sanofi Recombinant Protein Therapeutics Product
Table 92. Sanofi Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 93. Sanofi Recent Development
Table 94. Ligand Company Detail
Table 95. Ligand Business Overview
Table 96. Ligand Recombinant Protein Therapeutics Product
Table 97. Ligand Revenue in Recombinant Protein Therapeutics Business (2019-2024) & (US$ Million)
Table 98. Ligand Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Protein Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Recombinant Protein Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Recombinant Hormones Features
Figure 4. Interferons Features
Figure 5. Interleukins Features
Figure 6. Hematopoietic Growth Factors Features
Figure 7. Others Features
Figure 8. Global Recombinant Protein Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Recombinant Protein Therapeutics Market Share by Application: 2023 VS 2030
Figure 10. Diabetes Case Studies
Figure 11. Dwarfism Case Studies
Figure 12. Heart Disease Case Studies
Figure 13. Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Recombinant Protein Therapeutics Report Years Considered
Figure 16. Global Recombinant Protein Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Recombinant Protein Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Recombinant Protein Therapeutics Market Share by Region: 2023 VS 2030
Figure 19. Global Recombinant Protein Therapeutics Market Share by Players in 2023
Figure 20. Global Top Recombinant Protein Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Therapeutics as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Recombinant Protein Therapeutics Revenue in 2023
Figure 22. North America Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Recombinant Protein Therapeutics Market Share by Country (2019-2030)
Figure 24. United States Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Recombinant Protein Therapeutics Market Share by Country (2019-2030)
Figure 28. Germany Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Recombinant Protein Therapeutics Market Share by Region (2019-2030)
Figure 36. China Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Recombinant Protein Therapeutics Market Share by Country (2019-2030)
Figure 44. Mexico Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Recombinant Protein Therapeutics Market Share by Country (2019-2030)
Figure 48. Turkey Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Recombinant Protein Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Eli Lilly Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 52. Merck Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 53. Roche Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 54. Biogen Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 55. Bayer Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 56. J&J Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 57. Amgen Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 58. Sanofi Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 59. Ligand Revenue Growth Rate in Recombinant Protein Therapeutics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
